Therapeutic Areas of Expertise Our experience
The Center for Pharmaceutical Research has completed over 730 clinical trials since 1986 in nearly all areas of multispecialty research. We have volunteer recruitment down to a fine science, and as a result consistently over-enroll in most studies we conduct.
For specific details and statistics regarding our previous studies, please explore our condition-specific links below. We think you'll like what you see.
Total number of previous allergy/asthma studies:
● 5 Asthma studies
● 5 Allergy studies
● 1 Dust Mite Allergy study
● 2 Ragweed Allergy study
● 1 Timothy Grass Allergy study
● 1 Cat Allergy study
Patient Population:
● Over 11,113 patients with asthma in our databases
● Over 8,125 patients with allergic rhinitis in our databases
● Pediatric, adolescent, adult, and geriatric patient populations
● Population includes mild, moderate, and severe asthma patients
Specialized Equipment and Staff:
● Spirometer (calibrated annually)
● Board-certified allergist investigator
● Board-certified pulmonologist investigator
● Coordinator with 7 years’ experience in allergy and immunology
Historical Statistics
Condition | Population | Enrollment Goal | Actual Enrollment | % of Enrollment Goal Met |
Ragweed Allergy | Adults | 10 | 18 | 180% |
Ragweed Allergy | Adults | 12 | 15 | 125% |
Asthma | Pediatric | 8 | 8 so far | ongoing |
Asthma | Adults | 8 | 7 so far | ongoing |
Dust Mite Allergy | Adolescents | 9 | ongoing | ongoing |
Total number of previous Alzheimer’s disease studies:
● 10 Alzheimer’s Disease studies
Patient Population:
● Over 1,411 patients with Alzheimer’s disease in our databases
Specialized Equipment and Staff:
- 2 coordinators with over 15 years of Alzheimer’s disease clinical trial experience
- 4 experienced raters and psychometricians. These professionals have been specifically trained to administer tests to Alzheimer’s patients and caregivers with the utmost care and sensitivity
Please see below for a list of some of the scales and evaluations we have previously administered:
NINCDS/ADRADA | DSM-IV | MMSE | Rosen Modified Hachinski | Ischemic Score |
NTB | DAD | ADAS-COG | CDR-SOB | NPI |
DS | RUD-Lite | QOL-AD | PPQSA | HUI |
● Comfortable infusion room with leather chairs, TV, DVD player, plants, etc.
● Infusion team, directed by our Nurse Practitioner
● Crash cart in infusion room
● 3.0 Tesla MRI and 1.5 Tesla MRI
● PET and CT Scan
Historical Statistics
Condition | Severity | Enrollment Goal | Enrollment Total | % of Enrollment Goal Met |
Alzheimer's Disease | Mild to Moderate | 7 | 13 | 186% |
Alzheimer's Disease | Mild to Moderate | 6 | 7 | 117% |
Alzheimer's Disease | Mild to Moderate | 8 | 6 | 75% |
Alzheimer's Disease | Mild to Moderate | No Goal | 10 | 100% |
Total number of previous dermatology studies:.
● 7 Psoriasis
● 1 Rosacea
● 1 Acne
● 3 Skin Infection
● 3 Herpes Zoster
Patient Population:
● 551 volunteers with psoriasis in our research database alone
● 342 volunteers with rosacea in our research database alone
● Large dermatology private practice database available for recruitment
Specialized Equipment and Staff:
● Board-certified dermatologist investigators
● High-resolution digital camera and color printer
● Experienced PASI raters on staff
Historical Statistics
Condition | Length of Enrollment | Total # Screened | Total # Enrolled |
Psoriasis | 2 months | 14 | 11 |
Psoriasis | 1 month | 10 | 9 |
Rosacea | 3 months | 20 | 18 |
Skin Infection | 5 months | 9 | 9 |
Skin Infection | Unk | 20 | 15 |
Total number of previous diabetes/diabetic peripheral neuropathy studies:
● 12 Type II Diabetes studies
● 1 Type I Diabetes study
● 1 Diabetic device study
● 1 Diabetic Foot Ulcer study
● 10 Diabetic Peripheral Neuropathy studies
Patient Population:
● Over 915 volunteers with DPN in our research database
● Over 2,696 volunteers with Diabetes in our research database
● Pediatric, adolescent, adult, and geriatric patient populations
Specialized Equipment and Staff
● Board-certified endocrinologist sub-investigators
● Board-certified neurologist sub-investigators
● 3 groups of family practice sub-investigators
● 3 Registered Dieticians
Historical Statistics
Condition | Enrollment Length | Enrollment Goal | Enrollment Total | % of Enrollment Goal Met |
Diabetes / Hypertension / Obesity | 2 months | 8 | 13 | 163% |
DPN | 8 months | 6 | 8 | 133% |
DPN | 11 months | 10 | 10 | 100% |
Type II Diabetes | 23 months | 25 | 48 | 192% |
DPN | unknown | 6 | 17 | 283% |
DPN | 8 months | 6 | 8 | 133% |
DPN | 7 months | 5 | 9 | 180% |
Total number of previous fibromyalgia studies:
● 10 fibromyalgia studies
Patient Population:
● Over 825 volunteers with fibromyalgia in our research database alone
Specialized Equipment and Staff
● Our staff is experienced in the use and administration of the following fibromyalgia assessment tools, among others:
ASEX | Medical Outcomes Study- Sleep Scale (MOS) |
BDI | Multidimensional Assessment of Fatigue (MAF) |
BDI-II | Hospital Anxiety and Depression Scale (HADS) |
F-HAQ | MINI Mental State Examination |
FIQ | Beck Depression Scale |
HAM-D | Workload Productivity and Activity Impairment Questionnaire |
MASQ | Profile of Mood States |
MFI | EuroQol Utility Assessment |
SDS | Patient Global Impression of Change |
SF-36 | SF-MPQ |
Historical Statistics
Phase | Enrollment Length | Enrollment Goal | Recruitment Total | Number Enrolled | Percentage of Enrollment Goal Met |
3 | 7 months | 10 | 47 | 20 | 200% |
3 | 7 months | 10 | 11 | 11 | 110% |
unk | 1 month | 8 | 11 | 10 | 125% |
3 | 4 months | 9 | 22 | 11 | 122% |
Total number of previous gastrointestinal studies:
● 8 Gastroduodenal Ulcer studies
● 6 Opioid Induced Constipation studies
● 1 Chronic Idiopathic Constipation study
● 5 Erosive Esophagitis/Heartburn studies
● 4 Irritable Bowel Syndrome studies
● 1 H. Pylori study
Patient Population:
● 212 volunteers with gastroduodenal ulcers in our research database
● 347 volunteers with constipation in our research database
● 2,282 volunteers with Erosive Esophagitis/Heartburn in our research database
● 972 volunteers with Irritable Bowel Syndrome in our research volunteer database
● Pediatric, adolescent, adult, and geriatric patient populations
Specialized Equipment and Staff
● Board-certified gastroenterologist sub-investigator on campus
Historical Statistics
Condition | Enrollment Length | Actual Enrollment | Enrollment Goal | % of Enrollment Goal Met |
Gastroduodenal Ulcer/OA/RA | 2.5 months | 43 | 40 | 107.50% |
Gastroduodenal Ulcer/OA | 7.5 months | 17 | 11 | 154.55% |
Gastroduodenal Ulcer/OA | 4 months | 12 | 6 | 200.00% |
Gastroduodenal Ulcer/OA | 3 months | 8 | 1 | 800.00% |
Erosive Esophagitis | unk | 4 | 4 | 100.00% |
Erosive Esophagitis | 4 months | 7 | 6 | 116.67% |
Total number of previous Healthy Volunteer studies:
● Vaccine Studies:
1 Anthrax vaccine (adult)
5 Avian flu vaccine (adult)
1 Botulism vaccine (adult)
1 Plague vaccine (adult)
2 DTP vaccine (adult)
1 Pediatric DTaP/IPV vaccine (pediatric)
20 Adult/elderly influenza vaccine (adult and geriatric)
4 Herpes zoster (adult)
2 Swine flu vaccine (adult)
2 Infant meningitis vaccine
2 Meningitis vaccine (infant)
3 Meningitis vaccine (pediatric, adolescent, and adult)
1 Influenza vaccine (pediatric)
1 C. Difficile vaccine (adult)
1 HPV vaccine (adolescent, adult)
1 Melanoma vaccine (adult)
4 Pneumonia vaccine (adult)
3 Hepatitis B vaccine (adult)
2 MMR vaccine (infants)
● Other Indications:
Blood draw studies
Observational men’s health studies
Flu Treatment studies
Heartburn studies
Diabetic device studies
X-ray studies
Birth control studies
Semen analysis studies
Flu swab/diagnostic
Patient Population:
● 4,200 volunteers ages birth to 1 year
● 5,600 volunteers ages 1 year to 2 years
● 6,400 volunteers ages 2 years to 5 years
● 5,600 volunteers ages 6 years to 11 years
● 6,200 volunteers ages 12 to 18
● 14,477 volunteers ages 18 years to 64 years
● 8,627 volunteers ages 65+
Specialized Equipment and Staff
● Separate unblinded pharmacy team
● 2 (2-8° C) locked drug refrigerators
● 1 (-20° C) locked drug freezer
● 1 (-70° C) locked drug freezer
● Overnight stay capabilities
● 4 temperature monitoring systems in each drug storage space
● Bio-Safety Level 2 certified
● Local IBC committee available
● PBMC sample experienced/capable
● Have served as the only site in the country for multiple phase I vaccine clinical trials
Total number of previous allergy/asthma studies:
● 20 High Cholesterol studies
Patient Population:
● Over 10,810 patients in our databases have high cholesterol
Specialized Equipment and Staff
● Board-certified endocrinologist investigator
● Board-certified cardiologist investigators
● 4 coordinators with cardiology/telemetry backgrounds, with over 25-years combined cardiology experience
● Phillips 3.0 Tesla MRS (Magnetic Resonance Spectroscopy). MRS provides quantitative hepatic triglyceride levels. Our facility is unique in the region in offering this cutting-edge technology
● Mercury sphygmomanometers and electric sphygmomanometers (calibrated annually)
● Cholestec machine
Historical Statistics
Description | Enrollment Goal | Actual Enrollment | % of Enrollment Goal Met |
Mixed Dyslipidemia | 6 | 11 | 183.33% |
Hyperlipidemia | 20 | 38 | 190.00% |
Dyslipidemia | 10 | 17 | 170.00% |
Hypercholesterolemia | 10 | 18 | 180.00% |
Hypercholesterolemia | 10 | 26 | 260.00% |
Hypercholesterolemia | 12 | 40 | 333.33% |
Hypercholesterolemia | 4 | 7 | 175.00% |
Dyslipidemia | 20 | 28 | 140.00% |
Dyslipidemia | 12 | 15 | 125.00% |
Total number of previous hypertension studies:
● 13 previous hypertension studies
Patient Population:
● Over 9,838 patients in our databases have hypertension
Specialized Equipment and Staff:
● Board-certified endocrinologist investigator
● Board-certified cardiologist investigators
● 4 coordinators with cardiology/telemetry backgrounds, with over 25-years combined cardiology experience
● Mercury sphygmomanometers and electric sphygmomanometers (calibrated annually)
Historical Statistics
Condition | Length of Enrollment | Sponsor's Enrollment Goal | Number of Subjects Screened | Number Actually Enrolled | % of Enrollment Goal |
High Risk Hypertension | 13 months | 12 | 15 | 11 | 92% |
High Risk Hypertension | 13 months | 12 | 21 | 17 | 142% |
Hypertension/ Obesity/Diabetes | 14 months | 8 | 25 | 13 | 163% |
Hypertension | 3 months | 5 | 24 | 23 | 460% |
Mild to Moderate Hypertension | Not Available | 12 | 78 | 24 | 200% |
Mild to Moderate Hypertension | Not Available | 6 | 6 | 6 | 100% |
Total number of previous Men’s Health studies:
● 8 Premature Ejaculation studies
● 5 Erectile Dysfunction studies
● 8 Benign Prostatic Hyperplasia studies
● 1 Hypogonadism study
Patient Population:
● 525 volunteers with erectile dysfunction in our research volunteer database
● 473 volunteers with premature ejaculation in our research volunteer database
● 709 volunteers with benign prostatic hyperplasia in our research volunteer database
● 527 male volunteers with hypogonadism in our research volunteer database
Specialized Equipment and Staff
Our experienced coordinators understand the sensitive nature of men’s health studies and go out of their way to make the subjects feel comfortable. In addition, our staff includes board-certified urologist sub-investigators. The Center for Pharmaceutical Research routinely conducts the following tests and men’s health assessment tools and tests, among others:
● IIEF Questionnaire
● Hospital Anxiety and Depression Scale
● MINI Mental State Examination
● Beck Depression Scale
● International Prostate Symptom Score
● International Index of Erectile Dysfunction
● Hamilton Rating Scale for Depression
● Hamilton Anxiety Rating Scale
Historical Statistics
Condition | Length of Enrollment | Sponsor's Enrollment Goal | Number of Subjects Screened | Number Actually Enrolled | % of Enrollment Goal |
Premature Ejaculation | 3 months | 10 | 66 | 66 | 660% |
Premature Ejaculation | 6 months | 10 | 43 | 27 | 270% |
Premature Ejaculation | 1 month | 8 | 32 | 22 | 220% |
Premature Ejaculation | 7 months | 10 | 61 | 46 | 460% |
Premature Ejaculation | 8 months | 10 | 35 | 35 | 350% |
Premature Ejaculation | 5 months | 10 | 31 | 24 | 240% |
Premature Ejaculation | 6 months | No Goal | 40 | 36 | No Goal |
Erectile Dysfunction | 2 months | 16 | 32 | 20 | 125% |
Erectile Dysfunction | 7 months | No Goal | 25 | 25 | No Goal |
BPH | 8 months | 2 | 17 | 17 | 850% |
BPH | 3 months | 9 | 23 | 12 | 133% |
Total number of previous migraine studies:
● 18 Migraine studies
Patient Population:
● 2,293 volunteers with migraines in our research volunteer database
Specialized Equipment and Staff:
● Board-certified neurologist investigator
Historical Statistics
Enrollment Length | Total Enrollment | Enrollment Goal | % of Enrollment Goal Met |
1 month | 23 | 8 | 288% |
1 month | 23 | 10 | 230% |
4.5 months | 30 | 10 | 300% |
5.5 months | 25 | 10 | 250% |
unk | 45 | 25 | 180% |
2 months | 35 | 20 | 175% |
Total number of previous Neuroscience and Psychiatry studies:
● 13 Insomnia studies
● 5 Major Depressive Disorder studies
● 2 General Anxiety Disorder studies
● 1 ADHD study
Patient Population:
● 2,557 volunteers with insomnia in our research volunteer database
● 1,137 volunteers with major depressive disorder
● 875 volunteers with generalized anxiety disorder
● 228 volunteers with ADHD
Specialized Equipment and Staff:
● Board-certified psychiatrist investigator
● Doctorate-level psychologist investigator
● 6 experienced raters/psychomatricians
Total number of previous Obesity studies:
● 12 Obesity studies
Patient Population:
● 10,344 volunteers with a BMI ≥25 in our research volunteer database
● 2,039 volunteers with a BMI ≥36 in our research volunteer database
Specialized Equipment and Staff:
● 2 Board-certified endocrinologist investigators
● 4 Registered dietitians
● Digital and Manual Scales
● Bariatric seating available
Historical Statistics
Condition | # of Subjects Screened | Enrollment Goal | Number Enrolled | % of Goal Met |
Dyslipidemia / Obesity | 22 | 12 | 15 | 125% |
Hypertension / Obesity / Diabetes | 25 | 8 | 13 | 163% |
Obesity | 26 | 10 | 17 | 170% |
Cardio/Obesity | 25 | 10 | 10 | 100% |
Obesity | 75 | 25 | 75 | 300% |
Total number of previous Osteoarthritis studies:
● 71 Osteoarthritis clinical trials
Patient Population:
● Over 5,136 volunteers with osteoarthritis in our research volunteer database
Specialized Equipment and Staff:
● Dr. Ervin is board-certified in internal medicine and rheumatology
● 2 Board-certified rheumatologist sub-investigators
● On-site DEXA machine
● On-site X-ray
● Fluroscopy and Ultrasound available for injections
● MRI and other diagnostic procedures available through our affiliates
Historical Statistics
Length of Enrollment | Enrollment Goal | Number of Subjects Screened | Actual Enrollment | % of Enrollment Goal |
5 months | 10 | 100 | 62 | 620% |
6 months | 12 | 42 | 28 | 233% |
7 months | 12 | 78 | 68 | 567% |
20 months | 15 | 49 | 37 | 247% |
3 months | 10 | 23 | 20 | 200% |
7 months | 10 | 48 | 32 | 320% |
3 months | 10 | 44 | 41 | 410% |
4 months | 7 | 19 | 16 | 229% |
3.5 months | 12 | 35 | 28 | 233% |
6 months | 10 | 62 | 51 | 510% |
2.5 months | 10 | 43 | 40 | 400% |
3 months | 10 | 50 | 27 | 270% |
Total number of previous Osteoporosis studies:
● 7 Osteoporosis studies
Patient Population:
● 1,113 volunteers with osteoporosis in our research volunteer database
Specialized Equipment and Staff
● The Center for Pharmaceutical Research provides all diagnostic equipment necessary for osteoporosis studies. Our facility includes:
On-site DEXA
On-site X-Ray
MRI and other diagnostic procedures are available through our affiliates
● Dr. Ervin is board-certified in internal medicine and rheumatology
● 2 additional sub-investigators board-certified in internal medicine and rheumatology
Total number of previous allergy/asthma studies:
● 1 Pediatric flu vaccine study
● 2 Infant meningitis vaccine studies
● 2 Adolescent meningitis B vaccine studies
● 1 DTap/IPV vaccine study
● 1 ADHD study
● 2 Infant formula studies
● 1 Timothy grass allergy study
● 1 Dust mite allergy study
● 1 Cat allergy study
● 2 Asthma studies
Patient Population:
● 28,000 Patients in pediatric private practice database
● 5,000 patients pediatric allergy practice database
● 2,197 pediatric patients in our research volunteer database
Specialized Equipment and Staff:
● 3 Board-certified pediatrician investigators
● 2 Pediatric nurse practitioner investigators
● 1 Pediatric allergist investigator
Historical Statistics
Condition | Age Range | Length of Enrollment | Sponsor’s Enrollment Goal | Number of Subjects Screened | Number Actually Enrolled | % of Enrollment Goal |
Pediatric Flu Vaccine | 2 to 18 | 1.5 months | 20 | 43 | 41 | 205% |
ADHD | 6 to 17 | 1 months | 12 | 21 | 13 | 108% |
Pediatric Meningitis Vaccine | 2 months | 2 months | 4 | 3 | 3 | 75% |
Meningitis B Vaccine | 10 to 13 | 6 months | 30 | 90 | 89 | 297% |
Meningitis B Vaccine | 11 to 17 | ongoing | 30 | 18 current, enrollment ongoing | 18 current, enrollment ongoing | ongoing |
Infant Formula | 14 days or less | ongoing | 8 | 9 current, enrollment ongoing | 9 current, enrollment ongoing | ongoing |
Timothy Grass Allergy | 5+ | 3.5 months | 8 | 17 | 5 | 71% |
Asthma | 4 to 11 | ongoing | 8 | 10 current, enrollment ongoing | 7 current, enrollment ongoing | ongoing |
Asthma | 12+ | ongoing | 8 | 8 current, enrollment ongoing | 8 current, enrollment ongoing | ongoing |
Infant Formula | 17 days | ongoing | 9 | ongoing | ongoing | ongoing |
DTaP/IPV Vaccine | 4 to 6 | ongoing | 50 | 46 current, enrollment ongoing | 45 current, enrollment ongoing | ongoing |
Meningitis Vaccine | 9 - 18 months | ongoing | 20 | 9 current, enrollment ongoing | 9 current, enrollment ongoing | ongoing |
Total number of previous Post-Herpetic Neuralgia studies:
● 10 Post-herpetic neuralgia studies
Patient Population:
● 450 volunteers with PHN in our research volunteer database
Specialized Equipment and Staff:
● Board-certified neurologist investigator
Historical Statistics
Condition | Enrollment Goal | Recruitment Total | Enrollment Total | % of Enrollment Goal Met |
PHN | 10 | 15 | 11 | 110.00% |
PHN | None | 8 | 6 | No Goal |
PHN | 4 | 25 | 9 | 225.00% |
PHN | 6 | 23 | 16 | 267% |
Total number of previous allergy/asthma studies:
● 36 Rheumatoid arthritis studies
Patient Population:
● 977 volunteers with rheumatoid arthritis in our research volunteer database
Specialized Equipment and Staff:
● Dr. Ervin is board-certified in rheumatology
● 2 additional board-certified rheumatologists
Historical Statistics
Condition | Length of Enrollment | Number of Subjects Screened | Sponsor's Enrollment Goal | Number Actually Enrolled | % of Enrollment Goal |
RA | 11 months | 13 | 5 | 10 | 200.00% |
RA | 9 months | 11 | 5 | 7 | 140.00% |
RA/OA | 7 months | 78 | 12 | 68 | 566.67% |
RA/OA | unk | ? | 6 | 7 | 116.67% |
RA/OA | 2.5 months | 43 | 10 | 40 | 400.00% |
RA | unk | 14 | No Goal | 13 | No Goal |
RA | unk | 34 | 15 | 30 | 200.00% |
Total number of previous Sleep Disorder studies:
● 14 Insomnia studies
Patient Population:
● 5,710 patients with insomnia in our databases
Specialized Equipment and Staff:
● AASM accredited sleep lab
● Our staff is experienced in the use of the following insomnia assessment tools, among others:
Insomnia Severity Index | Tyrer Questionnaire |
Hospital Anxiety and Depression Scale | Patient Global Impression |
MINI Mental State Examination | Beck Depression Scale |
Functional Outcomes of Sleep Questionnaire | Sleep Diaries (Paper, Electronic, and IVRS) |
Sheehan Disability Scale | Profile of Mood States |
Health Economics Assessment |
Historical Statistics
Condition | Length of Enrollment | Sponsor's Enrollment Goal | Number of Subjects Screened | Number Actually Enrolled | % of Enrollment Goal |
Elderly Insomnia | 5 months | 8 | 19 | 7 | 88% |
Elderly Insomnia | 7 months | 10 | 24 | 16 | 160% |
Elderly Insomnia | 5 months | 10 | 10 | 10 | 100% |
Insomnia | 14 months | 10 | 26 | 8 | 80% |
Insomnia | 13 months | 10 | 46 | 33 | 330% |
Insomnia | 3 months | 12 | 25 | 18 | 150% |
Insomnia | 3 months | 10 | 16 | 15 | 150% |
Total number of previous Smoking Cessation studies:
● 6 Smoking cessation studies
5 Studies involving tobacco products
2 Studies using nicotine replacement therapies
Patient Population:
● Over 11,872 patients in our databases who currently smoke
Specialized Equipment and Staff
● 3 board-certified pulmonologist sub-investigators
● 1 board-certified psychiatrist sub-investigator
● 1 psychologist sub-investigator
● Experienced Tobacco Dependency and Cessation counselors
● 4 registered dieticians
Missouri Smoking Statistics:
Smoking continues to be a major health concern in Missouri, as Missouri’s smoking rates remain high above the national average. According to a 2010 report for the Centers for Disease Control and Prevention, * Missouri has the fourth highest smoking rate in the nation.
● Over 25% (1,120,000 people) of adults in Missouri smoke.
The national median is 18.4%
● 11.8% of Missouri adolescents ages 12-17 smoke.
The national average is 10.1%
● 24.6% of Kansas City residents smoke (418,200 people)
● Nearly 50% of Kansas City smokers have tried to quit smoking in the past.
Total number of previous Urology studies:
● 5 Erectile Dysfunction
● 8 Premature Ejaculation
● 8 Benign Prostatic Hyperplasia
● 3 Urinary Tract Infections
● 4 Overactive Bladder
● 1 Stress Urinary Incontinence
● 1 Semen Analysis
Research Database Patient Population:
● 525 volunteers with erectile dysfunction
● 473 volunteers with premature ejaculation
● 709 volunteers with benign prostatic hyperplasia
● 340 volunteers with history of UTI
● 528 volunteers with overactive bladder
● 179 volunteers with stress urinary incontinence
Specialized Equipment and Staff
● Board-certified urologist investigators in our building
● Coordinator with 13 years of experience in urology studies
● Work with local, specialized lab for semen analysis tests
● Bladder scanner for post-void residual measurements available on-site
The Center for Pharmaceutical Research (CPR) has conducted 32 vaccine studies including 15 flu, 2 swine flu, 3 avian flu, 2 herpes zoster, 3 pneumonia, 2 DTP, 1 botulism/bio-terrorism, 2 hepatitis B, 1 pediatric flu, and 1 pediatric meningitis. Our site is a consistent topenroller, usually randomizing 60-80 volunteers per day and completing enrollment in less than 3 days. CPR averages 107 randomized subjects per vaccine study, and has enrolled as many as 313 in a single study.
Since 2005, CPR has enrolled over 2,938 total volunteers in vaccine clinical trials. For most studies, all patients are recruited from our patient database with no advertising. Please see enrollment statistics from previous studies below.
Historical Statistics
Indication | Enrollment Time | Enrollment Length | Actual Enrollment | Enrollment Goal | % of Enrollment Goal Met |
Flu Vaccine | 1 | month | 153 | 90 | 170% |
DTP Vaccine Study | 0.50 | month | 37 | 50 | 100.% |
Flu Vaccine | 3 | months | 291 | 200 | 145% |
Pneumonia Vaccine | 1 | month | 99 | 40 | 247% |
Herpes Zoster Vaccine | 8 | months | 313 | 240 | 130% |
Flu Vaccine | 0.25 | month | 89 | 48 | 185% |
Flu Vaccine | 0.50 | month | 128 | 75 | 170% |
Flu Vaccine | 0.10 | month | 130 | 75 | 173% |
Pneumonia Vaccine | 3.50 | months | 52 | 48 | 108% |
Avian Flu Vaccine (H5N1) | 0.75 | month | 70 | 70 | 100% |
Avian Flu Vaccine (H5N1) | 0.10 | month | 81 | 63 | 129% |
Flu Vaccine | 0.06 | month | 80 | 80 | 100% |
Botulism Vaccine | 5 | months | 92 | 70 | 131% |
Flu Vaccine | 1 | month | 139 | 100 | 139% |
Flu Vaccine | 0.50 | month | 151 | 121 | 124% |
Flu Vaccine | 0.25 | month | 38 | No Goal | 100.00% |
Flu Vaccine | 0.50 | month | 91 | 107 | 85% |
Flu Vaccine | 0.50 | month | 163 | 144 | 113% |
Herpes Zoster Vaccine | 0.75 | month | 83 | 27 | 307% |
Flu Vaccine (Nasal) | 0.13 | month | 100 | 100 | 100% |
Flu Vaccine | 0.07 | month | 75 | 75 | 100% |
DTP Vaccine Study | 1.50 | months | 26 | No Goal | 100% |
Swine Flu (H1N1) Vaccine | 0.06 | month | 60 | 60 | 100% |
Flu Vaccine | 0.07 | month | 43 | No Goal | 100% |
Avian Flu Vaccine (H5N1) | 10 | month | 91 | 16 | 569% |
Swine Flu (H1N1) Vaccine | 0.75 | month | 115 | 100 | 115% |
Pediatric Meningitis Vaccine | 2 | months | 3 | 4 | 75% |
Hepatitis B Vaccine in pts with CKD | 11 | months | 20 | 16 | 125% |
Pneumonia Vaccine | 1.50 | months | 42 | 42 | 100% |
Pediatric Flu Vaccine | 1.50 | months | 41 | 20 | 205% |
Hepatitis B Vaccine in healthy volunteers | 0.13 | month | 68 | 50 | 136% |
Flu Vaccine | 0.75 | month | 39 | 39 | 100% |
Plague Vaccine | 1.25 | months | 37 | 36 | 103% |
Herpes Zoster Vaccine | 10 | months | 36 | 39 | 92% |
Avian Flu Vaccine (H5N1) | 0.75 | month | 15 | 15 | 100% |
Herpes Zoster Vaccine | 9 | months | 29 | 28 | 103% |
Flu Vaccine (Universal) | 0.50 | month | 16 | 16 | 100% |
C. Difficile | 7 | 7 | 100% | ||
Flu Vaccine | 0.50 | month | 180 | 145 | 124% |
Avian Flu Vaccine (H5N1) | 2 | months | 50 | 50 | 100% |
Meningitis Vaccine | 7 | months | 89 | 30 | 297% |
Total number of previous Women’s Health studies:
● 5 Low libido/HSDD/FSD
● 2 Genital herpes
● 1 Stress urinary incontinence
● 4 Overactive bladder
● 3 Urinary tract infection
● 1 Hormone replacement therapy
● 6 Osteoporosis
● 5 Birth Control
● 2 Heavy menstrual bleeding
● 1 Hot flash
● 1 Menstrual migraine
Research Database Patient Population:
● 297 volunteers with low libido
● 84 volunteers with genital herpes
● 146 volunteers with stress urinary incontinence
● 379 volunteers with overactive bladder
● 283 volunteers with history of urinary tract infection
● 991 volunteers with osteoporosis
● 182 volunteers with heavy menstrual bleeding
● 324 volunteers with hot flashes
● 1,729 volunteers with migraines
Specialized Equipment and Staff
Our staff includes several OB-GYN sub-investigators and a coordinator with over 31 years of women’s health experience. The Center for Pharmaceutical Research routinely conducts the following tests and women’s health assessment tools and tests, among others:
● PAP and Pelvic
● Colposcopy
● Endometrial Biopsy
● Ultrasound, pelvic and vaginal
● Female Sexual Distress Scale
● Female Sexual Functioning
● Sexual Interest & Desire Inventory
● Vasomotor symptom Questionnaire
● Beck’s Depression Inventory
● Patient Global Impression
● Evaluation of Virilization
● Quality of Life Questionnaires